Table 2 Distribution of each category of gingival lesions according to the patients’ gender and age
|  | Male (n = 359) | Female (n = 640) | Total (n = 999) | P value | Mean ± SD |
|---|---|---|---|---|---|
Reactive soft tissue lesions | 280 (28) | 437 (43.7) | 717 (71.8) | 0.001* | 36.92 ± 18.53 |
Benign mesenchymal neoplasms | 9 (0.9) | 17 (1.7) | 26 (2.6) | 0.948 | 37.32 ± 19.09 |
Malignant mesenchymal tumors | 3 (0.3) | 4 (0.4) | 7 (0.7) | 0.990 | 43.42 ± 18.20 |
Benign epithelial lesions | 17 (1.7) | 27 (2.7) | 44 (4.4) | 0.825 | 44.68 ± 14.05 |
Malignant epithelial tumors | 17 (1.7) | 13 (1.3) | 30 (3) | 0.027* | 59.13 ± 13.40 |
Immune-mediated diseases | 8 (0.8) | 82 (8.2) | 90 (9) | 0.001* | 45.65 ± 12.18 |
Salivary gland malignancies | 0 | 2 (0.2) | 2 (0.2) | 0.747 | 41.00 ± 15.55 |
Periodontal lesions | 0 | 12 (1.2) | 12 (1.2) | 0.021* | 27.08 ± 15.29 |
Odontogenic lesions | 0 | 4 (0.4) | 4 (0.4) | 0.327 | 22.50 ± 7.18 |
Hematopoietic lesions | 1 (0.1) | 3 (0.3) | 4 (0.4) | 0.947 | 38.12 ± 34.68 |
Physical and chemical irritation | 2 (0.2) | 4 (0.4) | 6 (0.6) | 0.769 | 28.00 ± 16.37 |
Non-specific lesions | 22 (2.2) | 35 (3.5) | 57 (5.7) | 0.77 | 39.63 ± 17.24 |